Viewing Study NCT00135395


Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2026-01-07 @ 6:50 AM
Study NCT ID: NCT00135395
Status: COMPLETED
Last Update Posted: 2010-02-05
First Post: 2005-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module